All News
Filter News
Found 808,991 articles
-
5 Biotechs Awaiting Big News From the FDA in July
7/6/2017
-
Soligenix Release: Dusquetide Technology Platform To Be Presented At The 2017 Drug Discovery And Therapy World Congress
7/6/2017
-
How To Be An Unforgettable Job Applicant
7/6/2017
-
Novo Nordisk A/S Release: Results From SWITCH Trials For Tresiba Published In The Journal Of The American Medical Association
7/6/2017
-
‘High Tech’ And Its Impact On Life Science Job Seekers
7/6/2017
-
A Type Of Drug Used By 50 Million Americans Has Been Linked To An Increased Risk Of Death, Washington University School of Medicine Reveals
7/6/2017
-
Interleukin Genetics Slashes 63% of Workforce, Shuts Down Program and Mulls Sale
7/6/2017
-
Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug
7/6/2017
-
5 Easy Steps To Generating Quick Job Referrals
7/6/2017
-
The 3 Most Desirable Skills In The ‘New Breed’ Of Pharma Sales Reps
7/6/2017
-
NantWorks' Soon-Shiong Buys Six California Hospitals
7/6/2017
-
Novartis AG Receives Approval In The EU For Cosentyx Label Update, Includes Long Term Superiority Data Versus Stelara In Psoriasis
7/6/2017
-
Bristol-Myers Squibb’s Orencia (Abatacept) Receives FDA Approval For Treatment Of Active Psoriatic Arthritis (PsA) in Adults
7/6/2017
-
China FDA Approves CTAs For BeyondSpring’s Second Global Plinabulin Registrational Trial For Chemotherapy-Induced Neutropenia Prevention
7/6/2017
-
Tonix Pharma Announces Conditional Acceptance Of Tonmya As Proposed Brand Name For TNX-102 SL (Cyclobenzaprine HCL Sublingual Tablets) For The Treatment Of PTSD
7/6/2017
-
Anthera Announces Expansion Of Screening In European Sites In Phase III RESULT Clinical Study Of Sollpura
7/6/2017
-
Prothena Announces Initiation Of Phase II PASADENA Study Of PRX002/RG7935 In Patients With Early Parkinson’s Disease
7/6/2017
-
Biohaven's BHV-5000 Receives Orphan Drug Designation From The FDA In Rett Syndrome
7/6/2017
-
TrovaGene Engages Leading CRO In AML To Conduct Phase Ib/II Trial Of PCM-075
7/6/2017
-
Shire Submits Investigational New Drug Application To FDA For Gene Therapy Candidate SHP654 For Treatment Of Hemophilia A
7/6/2017